Legend Biotech Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio9.5238.3671.42104.2549.80
P/B Ratio5.748.7411.239.376.25
Price/Tangible Book5.758.7711.289.436.28
Enterprise Value Ratios
EV/Revenue8.1434.4965.7696.0842.17
Profitability & Returns
Return on Equity (ROE)-0.15%-0.52%-0.59%-0.59%-0.71%
Return on Assets (ROA)-0.11%-0.17%-0.23%-0.27%-0.28%
Return on Invested Capital (ROIC)-1.13%-3.22%-94.34%-7.70%-4.88%
Return on Capital Employed (ROCE)-0.22%-0.27%-0.44%-0.44%-0.38%
Leverage & Solvency Ratios
Debt/Equity0.340.260.380.160.01
Liquidity Ratios
Current Ratio4.626.923.694.145.14
Quick Ratio4.496.773.594.115.09
Efficiency Ratios
Asset Turnover0.360.180.100.070.15
Inventory Turnover29.9135.3566.27176.58157.02
Yield & Distribution Ratios
Earnings Yield-0.03%-0.05%-0.05%-0.06%-0.07%
FCF Yield-0.03%-0.04%-0.03%-0.03%-0.07%
Buyback Yield-0.04%-0.11%-0.13%-0.19%-0.18%